US Stock MarketDetailed Quotes

MGRM Monogram Orthopaedics

Watchlist
  • 1.970
  • -0.010-0.51%
Close Nov 22 16:00 ET
  • 2.020
  • +0.050+2.54%
Post 18:43 ET
67.60MMarket Cap-4291P/E (TTM)

Monogram Orthopaedics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-170.13%-4.49M
51.97%-2.83M
-26.66%-3.65M
-60.85%-13.54M
-90.19%-3.11M
3.19%-1.66M
-324.71%-5.89M
21.69%-2.88M
8.16%-8.42M
-1.64M
Net income from continuing operations
-405.64%-5.03M
32.46%-3.54M
9.10%-3.51M
-0.40%-13.75M
-17.48%-3.65M
76.39%-995.66K
-181.67%-5.24M
14.36%-3.86M
-15.88%-13.69M
---3.11M
Operating gains losses
----
----
----
-190.00%-3.09M
--0
-208.59%-2.65M
-909.82%-439.61K
-100.34%-2.52K
119.51%3.43M
--201.24K
Depreciation and amortization
5.10%108.37K
5.08%106.85K
3.31%105.9K
6.63%412.34K
4.34%105.04K
5.56%103.11K
10.90%101.68K
6.06%102.5K
20.09%386.69K
--100.67K
Other non cash items
--0
--12.5K
--37.5K
13,000,100.00%130K
--50K
----
----
----
---1
----
Change In working capital
-93.29%95.39K
140.55%294.25K
-223.73%-627.61K
61.48%1.15M
-107.78%-57.49K
1,812.43%1.42M
-608.87%-725.74K
670.73%507.23K
27.63%709.57K
--738.85K
-Change in receivables
69.54%-1.26K
-69.54%1.26K
--365K
-1,761.29%-357.89K
---357.89K
---4.14K
--4.14K
--0
452.36%21.54K
----
-Change in prepaid assets
----
----
----
42.02%269.7K
----
----
----
----
1,604.42%189.91K
----
-Change in payables and accrued expense
-106.11%-32.17K
283.26%479.72K
-423.01%-882.65K
147.73%1.23M
-63.13%309.41K
959.90%526.15K
172.09%125.17K
357.38%273.26K
-3.53%498.12K
--839.11K
-Change in other current assets
-85.68%128K
78.27%-185.25K
-148.14%-111.45K
----
----
2,319.31%894.16K
-369.39%-852.6K
1,252.01%231.52K
----
----
-Change in other working capital
----
----
-39.29%1.49K
----
----
----
----
1,305.75%2.45K
----
----
Cash from discontinued investing activities
Operating cash flow
-170.13%-4.49M
51.97%-2.83M
-26.66%-3.65M
-60.85%-13.54M
-90.19%-3.11M
3.19%-1.66M
-324.71%-5.89M
21.69%-2.88M
8.16%-8.42M
---1.64M
Investing cash flow
Cash flow from continuing investing activities
-985.22%-36.42K
0
23.01%-11.39K
73.09%-64.91K
30.31%-24.15K
98.17%-3.36K
0.29%-22.62K
-14.79K
76.03%-241.2K
-34.65K
Net PPE purchase and sale
-985.22%-36.42K
--0
23.01%-11.39K
73.09%-64.91K
30.31%-24.15K
98.17%-3.36K
0.29%-22.62K
---14.79K
-675.40%-241.2K
---34.65K
Cash from discontinued investing activities
Investing cash flow
-985.22%-36.42K
--0
23.01%-11.39K
73.09%-64.91K
30.31%-24.15K
98.17%-3.36K
0.29%-22.62K
---14.79K
76.03%-241.2K
---34.65K
Financing cash flow
Cash flow from continuing financing activities
2,575.18%13.78M
-99.64%55.64K
2.49%150.7K
23.06%16.73M
-39.36%1.85M
-179.87%-556.92K
1,733.30%15.29M
-98.37%147.04K
34.28%13.59M
3.05M
Net common stock issuance
11,934.30%3.97M
-99.64%55.64K
--150.7K
--15.33M
--76.46K
---33.56K
--15.29M
--0
--0
--0
Net preferred stock issuance
--9.81M
--0
--0
-98.92%147.04K
--0
--0
--0
-98.37%147.04K
34.28%13.59M
--3.28M
Proceeds from stock option exercised by employees
----
----
----
--1.25M
----
----
----
----
--0
----
Cash from discontinued financing activities
Financing cash flow
2,575.18%13.78M
-99.64%55.64K
2.49%150.7K
23.06%16.73M
-39.36%1.85M
-179.87%-556.92K
1,733.30%15.29M
-98.37%147.04K
34.28%13.59M
--3.05M
Net cash flow
Beginning cash position
-57.27%7.31M
30.56%10.08M
29.81%13.59M
89.11%10.47M
63.66%14.88M
66.12%17.1M
-28.97%7.72M
89.11%10.47M
-0.91%5.54M
--9.09M
Current changes in cash
516.66%9.26M
-129.55%-2.77M
-27.68%-3.51M
-36.74%3.12M
-193.26%-1.29M
-84.67%-2.22M
1,732.07%9.38M
-151.58%-2.75M
9,765.22%4.93M
--1.38M
End cash Position
11.36%16.57M
-57.27%7.31M
30.56%10.08M
29.81%13.59M
29.81%13.59M
63.66%14.88M
66.12%17.1M
-28.97%7.72M
89.11%10.47M
--10.47M
Free cash flow
-171.77%-4.53M
52.15%-2.83M
-26.40%-3.66M
-57.12%-13.61M
-87.69%-3.14M
12.38%-1.67M
-319.48%-5.91M
21.29%-2.9M
14.87%-8.66M
---1.67M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -170.13%-4.49M51.97%-2.83M-26.66%-3.65M-60.85%-13.54M-90.19%-3.11M3.19%-1.66M-324.71%-5.89M21.69%-2.88M8.16%-8.42M-1.64M
Net income from continuing operations -405.64%-5.03M32.46%-3.54M9.10%-3.51M-0.40%-13.75M-17.48%-3.65M76.39%-995.66K-181.67%-5.24M14.36%-3.86M-15.88%-13.69M---3.11M
Operating gains losses -------------190.00%-3.09M--0-208.59%-2.65M-909.82%-439.61K-100.34%-2.52K119.51%3.43M--201.24K
Depreciation and amortization 5.10%108.37K5.08%106.85K3.31%105.9K6.63%412.34K4.34%105.04K5.56%103.11K10.90%101.68K6.06%102.5K20.09%386.69K--100.67K
Other non cash items --0--12.5K--37.5K13,000,100.00%130K--50K---------------1----
Change In working capital -93.29%95.39K140.55%294.25K-223.73%-627.61K61.48%1.15M-107.78%-57.49K1,812.43%1.42M-608.87%-725.74K670.73%507.23K27.63%709.57K--738.85K
-Change in receivables 69.54%-1.26K-69.54%1.26K--365K-1,761.29%-357.89K---357.89K---4.14K--4.14K--0452.36%21.54K----
-Change in prepaid assets ------------42.02%269.7K----------------1,604.42%189.91K----
-Change in payables and accrued expense -106.11%-32.17K283.26%479.72K-423.01%-882.65K147.73%1.23M-63.13%309.41K959.90%526.15K172.09%125.17K357.38%273.26K-3.53%498.12K--839.11K
-Change in other current assets -85.68%128K78.27%-185.25K-148.14%-111.45K--------2,319.31%894.16K-369.39%-852.6K1,252.01%231.52K--------
-Change in other working capital ---------39.29%1.49K----------------1,305.75%2.45K--------
Cash from discontinued investing activities
Operating cash flow -170.13%-4.49M51.97%-2.83M-26.66%-3.65M-60.85%-13.54M-90.19%-3.11M3.19%-1.66M-324.71%-5.89M21.69%-2.88M8.16%-8.42M---1.64M
Investing cash flow
Cash flow from continuing investing activities -985.22%-36.42K023.01%-11.39K73.09%-64.91K30.31%-24.15K98.17%-3.36K0.29%-22.62K-14.79K76.03%-241.2K-34.65K
Net PPE purchase and sale -985.22%-36.42K--023.01%-11.39K73.09%-64.91K30.31%-24.15K98.17%-3.36K0.29%-22.62K---14.79K-675.40%-241.2K---34.65K
Cash from discontinued investing activities
Investing cash flow -985.22%-36.42K--023.01%-11.39K73.09%-64.91K30.31%-24.15K98.17%-3.36K0.29%-22.62K---14.79K76.03%-241.2K---34.65K
Financing cash flow
Cash flow from continuing financing activities 2,575.18%13.78M-99.64%55.64K2.49%150.7K23.06%16.73M-39.36%1.85M-179.87%-556.92K1,733.30%15.29M-98.37%147.04K34.28%13.59M3.05M
Net common stock issuance 11,934.30%3.97M-99.64%55.64K--150.7K--15.33M--76.46K---33.56K--15.29M--0--0--0
Net preferred stock issuance --9.81M--0--0-98.92%147.04K--0--0--0-98.37%147.04K34.28%13.59M--3.28M
Proceeds from stock option exercised by employees --------------1.25M------------------0----
Cash from discontinued financing activities
Financing cash flow 2,575.18%13.78M-99.64%55.64K2.49%150.7K23.06%16.73M-39.36%1.85M-179.87%-556.92K1,733.30%15.29M-98.37%147.04K34.28%13.59M--3.05M
Net cash flow
Beginning cash position -57.27%7.31M30.56%10.08M29.81%13.59M89.11%10.47M63.66%14.88M66.12%17.1M-28.97%7.72M89.11%10.47M-0.91%5.54M--9.09M
Current changes in cash 516.66%9.26M-129.55%-2.77M-27.68%-3.51M-36.74%3.12M-193.26%-1.29M-84.67%-2.22M1,732.07%9.38M-151.58%-2.75M9,765.22%4.93M--1.38M
End cash Position 11.36%16.57M-57.27%7.31M30.56%10.08M29.81%13.59M29.81%13.59M63.66%14.88M66.12%17.1M-28.97%7.72M89.11%10.47M--10.47M
Free cash flow -171.77%-4.53M52.15%-2.83M-26.40%-3.66M-57.12%-13.61M-87.69%-3.14M12.38%-1.67M-319.48%-5.91M21.29%-2.9M14.87%-8.66M---1.67M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data